‘You can’t rush science’ — Merck CEO stresses need for careful approach to coronavirus vaccine

CNBC News

9 September 2020 - Frazier’s Merck was among the nine companies that signed a pledge to prioritise safety as the drugmakers seek regulatory approval.

Merck CEO Kenneth Frazier on Wednesday emphasised the need for patience and strict adherence to scientific principles in the global push to develop a vaccine to prevent the coronavirus.

“I know there are a lot of public voices talking about when vaccines will be ready, but the fact of the matter is you can’t rush science,” Frazier said on CNBC’s “Fast Money: Halftime Report.”

Read CNBC News article 

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Timelines , Vaccine , Safety , COVID-19